Investigation of Radiolabeling Efficacy by Enhancement of the Chemical form of no Carrier Added Lu Isolated by Electro Amalgamation Process.

Background: Due to the suitable nuclear decay characteristics, Lu is an attractive radionuclide for various therapeutic applications. The non-carrier added form ofLu has drawn much attention because of its high specific activity needed in radiolabeling studies. There have been several separation methods for NCALu production.

Preparation and Dosimetry Evaluation of a Carrier- Free 90Y Labeled DOTMP as a Promising Agent for Bone Marrow Ablation.

Background And Objective: Skeletal uptake of 90Y-1,4,7,10-tetraazacyclododecane-1,4,7,10- tetramethylene-phosphonate (DOTMP) is used to deliver high doses of this radiopharmaceutical to the bone marrow.

Methods: In this research, carrier-free (c.f.

Production, quality control, and bio-distribution studies of (159)Gd-EDTMP as a palliative agent for bone pain.

Introduction: Particle-emitting, bone-seeking radiopharmaceuticals have attracted the attention of the nuclear medicine community over the last three decades for the treatment of the pain of osteoblastic metastases. The objectives of this research were to produce quality-controlled (159)Gd-EDTMP in order to provide a new therapeutic radiopharmaceutical for use in clinical applications.

Methods: The investigation was an experimental study in which (159)Gd (T1/2=18.